Predictive Oncology Inc.
13F holders, Q2 2025 (June 30)12holders −2
2new positions
4sold out
$0.83avg. 13F price*
At the end of Q2 2025, 12 institutions reported holding Predictive Oncology Inc. in their 13F filings, down 2 from Q1 2025. 2 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($59K), Geode Capital Management, LLC ($52K) and Virtu Financial LLC ($13K).
- Company
- Predictive Oncology Inc.
- CUSIP
- 74039M309
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $16K |
| Exits | 4 | $30K |
All 13F filers, Q1 2025 → Q2 2025: 20,373 shares bought and 23,175 shares sold, net −2,802 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Vanguard Group Inc. | 0.00% | No change | 71,307 | $59K |
| Geode Capital Management, LLC | 0.00% | Add +0.4% | 63,180 | $52K |
| Virtu Financial LLC | 0.00% | New | 16,228 | $13K |
| State Street Corp. | 0.00% | No change | 13,837 | $11K |
| Carnegie Mellon University | 0.01% | No change | 10,358 | $9K |
| Raymond James Financial Inc. | 0.00% | New | 3,869 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -71.1% | 1,504 | $1K |
| Wells Fargo & Company | 0.00% | No change | 1,000 | $830 |
| Osaic Holdings, Inc. | 0.00% | No change | 425 | $352 |
| Bank of America Corp. | 0.00% | Add +50.9% | 80 | $66 |
| SBI Securities Co., Ltd. | 0.00% | No change | 5 | $4 |
| Royal Bank of Canada | 0.00% | No change | 50 | $0 |
"% of holder's portfolio" is PREDICTIVE ONCOLOGY INC's weight in each manager's 13F, not the share of Predictive Oncology Inc. the manager owns.